Synthetic biology play Senti emerges with $53M series A

By Allison Johnson | Mar 2, 2018 | 5:33 PM GMT

Senti Biosciences Inc. (South San Francisco, Calif.) announced a tranched $53 million series A round led by existing investor New Enterprise

Read the full 215 word article

How to gain access

Continue reading with a
two-week free trial.